MIRA INFORM REPORT

 

 

Report Date :

18.01.2013

 

IDENTIFICATION DETAILS

 

Name :

VEIOVIS LIFESCIENCES P.LTD.

 

 

Registered Office :

Teku,, 2nd Floor, Kathmandu

 

 

Country :

Nepal

 

 

Date of Incorporation :

24.8.2011

 

 

Legal Form :

Private Limited Company

 

 

Line of Business :

This section contains Medicine institutions like: Medicine (related) Universities, Medicine Organisations, Medicine  Registration Authorities, Organizers, Publishers.

 

 

No. of Employees :

Not Available

 

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Status :

Satisfactory

Payment Behaviour :

No Complaints

Litigation :

Clear

 

 

NOTES :

Any query related to this report can be made on e-mail: infodept@mirainform.com while quoting report number, name and date.

 

ECGC Country Risk Classification List – June 30th, 2012

 

Country Name

Previous Rating

(31.03.2011)

Current Rating

(30.06.2012)

Nepal

B1

B1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

NEPAL - ECONOMIC OVERVIEW

 

Nepal is among the poorest and least developed countries in the world, with with about one-third of its population living below the poverty line. Agriculture is the mainstay of the economy, providing a livelihood for three-fourths of the population and accounting for about one-third of GDP. Industrial activity mainly involves the processing of agricultural products, including pulses, jute, sugarcane, tobacco, and grain. Nepal has considerable scope for exploiting its potential in hydropower, with an estimated 42,000 MW of feasible capacity, but political instability hampers foreign investment. Additional challenges to Nepal's growth include its landlocked geographic location, civil strife and labor unrest, and its susceptibility to natural disaster.

Source : CIA

Company name and address

 

Veiovis Lifesciences P.Ltd.
Teku,, 2nd Floor, Kathmandu
Nepal

 

Ph: 009771- 4225360, 009771- 4216154
Fax 009771- 4249461
Mob: 00977-9851021528
Mail : hos@mail

 

 

Summary

 

History :                       It is a private limited company incorporated at Kathmandu under His Majesty Govt.

                                    Act No.68422 of 24.8.2011

 

 

Directors :         1.         Bijay Agrawal

 

Bankers :          1.         Nepal Grindlays Bank, Kathmandu (Nepal)

 

Shareholders:                Director and Their relative holds 60% all shares.
                                    Foreign holds 40% 

 

Auditors:                       N. Tuladhar & Co., New Road., Kathmandu (Nepal)

 

Business:                      This section contains Medicine institutions like: Medicine (related) Universities, Medicine Organisations, Medicine  Registration Authorities, Organizers, Publishers.

Institutions are listed in this section with a comprehensive listing of contact details and a summary of activities. Your institution can be listed today for free.

 

Trade trams       :           Koria, Singapore & Holland

 

Financial:                                             

 

Authorised Capital : 10,000,000/- (1,000,000 Equity Shares of Np Rs.10/- each)

Paidup                     : 7,654,000/- (765,400 of Np  Rs.10/- each)

 

 

 

 

 

 

 

 

Remarks :                     Newly started concern. Payments are reported to be correct and regular as per commitments.  Trade relations are fair. Business may be done on meright. 


 

FOREIGN EXCHANGE RATES

 

Currency
Unit

Indian Rupees

US Dollar

1

Rs.54.64

UK Pound

1

Rs.87.45

Euro

1

Rs.72.65

 

 

INFORMATION DETAILS

 

Report Prepared by :

PRL

 

 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

--

NB

New Business

 

--

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.